Marker Therapeutics Inc
NASDAQ:MRKR
Marker Therapeutics Inc
NASDAQ:MRKR
Price:
1.34
USD
1.52%
Market Closed
Market Cap:
$22.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
US |
|
3
|
3P Land Holdings Ltd
NSE:3PLAND
|
IN |
|
China Longyuan Power Group Corp Ltd
HKEX:916
|
CN |
|
I
|
Isbir Sentetik Dokuma Sanayi AS
IST:ISSEN.E
|
TR |
|
Environmental Waste International Inc
XTSX:EWS
|
CA |
|
China Information Technology Development Ltd
HKEX:8178
|
HK |
|
H
|
Hatcher Group Ltd
HKEX:8365
|
HK |
|
Pasupati Acrylon Ltd
NSE:PASUPTAC
|
IN |
|
GS Yuasa Corp
TSE:6674
|
JP |
|
Daiwa Securities Group Inc
TSE:8601
|
JP |
|
C
|
China Southern Power Grid Technology Co Ltd
SSE:688248
|
CN |
|
Yamato Industry Co Ltd
TSE:7886
|
JP |
|
M
|
MeereCompanyInc
KOSDAQ:049950
|
KR |
|
Proteome Sciences PLC
LSE:PRM
|
UK |
|
E
|
ELQ SA
WSE:ELQ
|
PL |
|
S
|
Sezzle Inc
NASDAQ:SEZL
|
US |
|
T
|
Thor Mining PLC
OTC:THORF
|
UK |
|
Genting Malaysia Bhd
OTC:GMALF
|
MY |
|
A
|
Anonymous Intelligence Company Inc
CNSX:ANON
|
CA |
|
Kohsoku Corp
TSE:7504
|
JP |
Relative Value
The Relative Value of one
MRKR
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.34 USD,
Marker Therapeutics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MRKR Relative Value
HIDDEN
Multiples Across Competitors
MRKR Competitors Multiples
Marker Therapeutics Inc Competitors
Marker Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
22.4m USD | 4.9 | -1.6 | -0.3 | -0.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 33.9 | 11.2 | 14.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
